You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Abiraterone%20Acetate

Showing 26 - 50 of 1,207
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Adenocarcinoma, Prostate Cancer, High Risk Prostate Cancer Trial in Baltimore, Boston, Seattle (Enzalutamide,

Completed
Has Results
  • Prostate Adenocarcinoma
  • +2 more
  • Baltimore, Maryland
  • +3 more
Mar 30, 2022

Metastatic Castration-resistant Prostate Cancer Trial in United Kingdom, United States (PLX2853, Olaparib, Abiraterone acetate)

Terminated
  • Metastatic Castration-resistant Prostate Cancer
  • Chicago, Illinois
  • +7 more
Oct 4, 2022

Metastatic Castration-resistant Prostate Cancer, Metastatic Breast Cancer Trial in Worldwide (Abiraterone acetate, Prednisone)

Completed
Has Results
  • Metastatic Castration-resistant Prostate Cancer
  • Metastatic Breast Cancer
  • Aurora, Colorado
  • +21 more
Apr 20, 2022

Prostate Cancer Trial in Canada, United States (Prednisone, Apalutamide, Abiraterone Acetate)

Recruiting
  • Prostate Cancer
  • Boston, Massachusetts
  • +5 more
Jul 14, 2022

Prostate Cancer Trial in Nanjing (Abiraterone Acetate, Prednisone, Goserelin 10.8 mg)

Active, not recruiting
  • Prostate Cancer
  • Abiraterone Acetate
  • +2 more
  • Nanjing, Jiangsu, China
    Department of Urology, Drum Tower Hospital, Medical School of Na
Dec 14, 2022

Prostate Cancer, Prostatic Tumor Trial in United States (abiraterone acetate in combination with prednisone)

Active, not recruiting
Has Results
  • Prostate Cancer
  • Prostatic Neoplasm
  • abiraterone acetate in combination with prednisone
  • Homewood, Alabama
  • +44 more
Jan 17, 2023

Prostate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v8, Stage IIC Prostate Cancer AJCC v8 Trial in Houston (drug,

Completed
Has Results
  • Prostate Adenocarcinoma
  • +4 more
  • Abiraterone Acetate
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 14, 2022

Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Without Neuroendocrine Differentiation, Stage IV Prostate

Suspended
  • Castration-Resistant Prostate Carcinoma
  • +4 more
  • Abiraterone Acetate
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 27, 2022

Prostatic Tumors, Castration-Resistant, Drug Therapy, Combination Trial in Chengdu (TQB3616 Capsules Combined With Abiraterone

Not yet recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • Drug Therapy, Combination
  • TQB3616 Capsules Combined With Abiraterone Acetate Plus Prednisone
  • Chengdu, Sichuan, China
    West China Hospital
Dec 12, 2021

Castration-Sensitive Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Prostate Carcinoma Trial in Seattle

Active, not recruiting
  • Castration-Sensitive Prostate Carcinoma
  • +7 more
  • Antiandrogen Therapy
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 8, 2022

Prostate Cancer Metastatic, Prostate Cancer Trial in Houston (Abiraterone Acetate, Prednisone)

Recruiting
  • Prostate Cancer Metastatic
  • Prostate Cancer
  • Houston, Texas
  • +2 more
Oct 7, 2022

Metastatic Hormone Refractory Prostate Cancer Trial in Saint Louis (Cabozantinib, Nivolumab, Abiraterone acetate)

Recruiting
  • Metastatic Hormone Refractory Prostate Cancer
  • Saint Louis, Missouri
    Washington University School of Medicine
Jun 6, 2022

Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer Trial in Sacramento (Abiraterone Acetate,

Active, not recruiting
  • Metastatic Prostate Carcinoma
  • +2 more
  • Abiraterone Acetate
  • +2 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Feb 23, 2022

Metastatic Prostate Carcinoma, Prostate Adenocarcinoma, Prostate Carcinoma Metastatic in the Bone Trial in Houston (Abiraterone

Active, not recruiting
  • Metastatic Prostate Carcinoma
  • +5 more
  • Abiraterone Acetate
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 26, 2022

Prostate Cancer Trial in Houston (Abiraterone Acetate, Prednisone, Sunitinib)

Active, not recruiting
  • Prostate Cancer
  • Abiraterone Acetate
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 6, 2022

Metastatic Castration-resistant Prostate Cancer Trial in China (olaparib, enzalutamide, abiraterone acetate)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Chengdu, China
  • +7 more
Aug 5, 2022

Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Duarte

Recruiting
  • Castration-Sensitive Prostate Carcinoma
  • +4 more
  • Abiraterone Acetate
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Oct 7, 2022

Prostate Cancer Metastatic Trial in Omaha, New York (Apalutamide, Abiraterone acetate, Docetaxel)

Active, not recruiting
  • Prostate Cancer Metastatic
  • Omaha, Nebraska
  • +1 more
Aug 26, 2021

Prostate Cancer Trial in Durham, Houston (Abiraterone acetate, Androgen deprivation, Radiation Therapy)

Active, not recruiting
Has Results
  • Prostate Cancer
  • Abiraterone acetate
  • +3 more
  • Durham, North Carolina
  • +2 more
Oct 27, 2021

Metastatic Castration-resistant Prostate Cancer Trial (Abiraterone Acetate)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Abiraterone Acetate
  • (no location specified)
Apr 19, 2022

Congenital Adrenal Hyperplasia Trial in United States (Abiraterone acetate)

Active, not recruiting
  • Congenital Adrenal Hyperplasia
  • Abiraterone acetate
  • Los Angeles, California
  • +3 more
Feb 22, 2022

Prostate Cancer Trial in United States (ARN-509, Abiraterone Acetate, Prednisone)

Active, not recruiting
  • Prostate Cancer
  • New Orleans, Louisiana
  • +13 more
Feb 5, 2022

Stage III Prostate Adenocarcinoma AJCC v7, Stage III Prostate Cancer AJCC v7, Stage IV Prostate Adenocarcinoma AJCC v7 Trial in

Completed
Has Results
  • Stage III Prostate Adenocarcinoma AJCC v7
  • +3 more
  • Abiraterone Acetate
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 15, 2021

Pharmacodynamic and Genetic Parameters of Abira-DES Study

Completed
  • Metastatic Castration-resistant Prostate Cancer
  • Serum and plasma samples analysis
  • São Paulo, Brazil
    Sociedade Beneficiante de Senhoras - Hospital Sirio Libanes
Dec 30, 2021

Prostate Cancer Trial in United States (Abiraterone acetate, Abiraterone acetate plus degarelix, Degarelix)

Completed
Has Results
  • Prostate Cancer
  • Abiraterone acetate
  • +2 more
  • Chicago, Illinois
  • +15 more
Oct 25, 2021